CollPlant Biotechnologies Ltd (CLGN)
6.33
-0.07
(-1.09%)
USD |
NASDAQ |
May 17, 16:00
6.33
0.00 (0.00%)
After-Hours: 20:00
CollPlant Biotechnologies Enterprise Value: 45.95M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 45.95M |
| May 16, 2024 | 46.63M |
| May 15, 2024 | 46.52M |
| May 14, 2024 | 48.10M |
| May 13, 2024 | 48.52M |
| May 10, 2024 | 49.25M |
| May 09, 2024 | 50.64M |
| May 08, 2024 | 44.80M |
| May 07, 2024 | 41.08M |
| May 06, 2024 | 40.33M |
| May 03, 2024 | 41.48M |
| May 02, 2024 | 44.17M |
| May 01, 2024 | 39.53M |
| April 30, 2024 | 40.68M |
| April 29, 2024 | 41.71M |
| April 26, 2024 | 40.79M |
| April 25, 2024 | 34.72M |
| April 24, 2024 | 35.29M |
| April 23, 2024 | 35.18M |
| April 22, 2024 | 33.58M |
| April 19, 2024 | 32.89M |
| April 18, 2024 | 33.12M |
| April 17, 2024 | 33.35M |
| April 16, 2024 | 32.45M |
| April 15, 2024 | 32.60M |
| Date | Value |
|---|---|
| April 12, 2024 | 33.40M |
| April 11, 2024 | 33.18M |
| April 10, 2024 | 33.35M |
| April 09, 2024 | 33.18M |
| April 08, 2024 | 31.87M |
| April 05, 2024 | 31.74M |
| April 04, 2024 | 33.58M |
| April 03, 2024 | 35.81M |
| April 02, 2024 | 33.58M |
| April 01, 2024 | 33.58M |
| March 28, 2024 | 34.61M |
| March 27, 2024 | 33.23M |
| March 26, 2024 | 33.35M |
| March 25, 2024 | 33.46M |
| March 22, 2024 | 31.74M |
| March 21, 2024 | 30.83M |
| March 20, 2024 | 32.43M |
| March 19, 2024 | 33.25M |
| March 18, 2024 | 31.16M |
| March 15, 2024 | 30.70M |
| March 14, 2024 | 34.25M |
| March 13, 2024 | 31.34M |
| March 12, 2024 | 31.51M |
| March 11, 2024 | 31.49M |
| March 08, 2024 | 29.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.08M
Minimum
Aug 01 2019
194.49M
Maximum
Oct 26 2021
64.30M
Average
55.80M
Median
Mar 09 2022
Enterprise Value Benchmarks
| Compugen Ltd | 138.22M |
| Pluri Inc | 33.13M |
| BioLine Rx Ltd | 17.94M |
| Can Fite Biofarma Ltd | 2.955M |
| BiomX Inc | 14.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.689M |
| Revenue (Quarterly) | 0.299M |
| Total Expenses (Quarterly) | 5.367M |
| EPS Diluted (Quarterly) | -0.42 |
| Gross Profit Margin (Quarterly) | -158.5% |
| Profit Margin (Quarterly) | -1.57K% |
| Earnings Yield | -10.09% |
| Normalized Earnings Yield | -10.09 |